Gopal Vyas

650 total citations
16 papers, 224 citations indexed

About

Gopal Vyas is a scholar working on Psychiatry and Mental health, Genetics and Clinical Psychology. According to data from OpenAlex, Gopal Vyas has authored 16 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 4 papers in Genetics and 3 papers in Clinical Psychology. Recurrent topics in Gopal Vyas's work include Schizophrenia research and treatment (9 papers), Blood disorders and treatments (3 papers) and Tryptophan and brain disorders (3 papers). Gopal Vyas is often cited by papers focused on Schizophrenia research and treatment (9 papers), Blood disorders and treatments (3 papers) and Tryptophan and brain disorders (3 papers). Gopal Vyas collaborates with scholars based in United States, Nigeria and Germany. Gopal Vyas's co-authors include Deanna L. Kelly, Charles M. Richardson, David Goldman, Ke Xu, Chiara Maria Mazzanti, Robert H. Lipsky, Heidi J. Wehring, Stephanie Feldman, Raymond C. Love and Robert P. McMahon and has published in prestigious journals such as Clinical Chemistry, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

Gopal Vyas

15 papers receiving 217 citations

Peers

Gopal Vyas

PMH

PHILO

Elena Garrido Spain

Masaki Hattori Japan

Sarah Bridge United Kingdom

Ian Atkinson Canada

Ruifang Cao China

Jaime Luna France

Eva Burkhardt Germany

A. Dourado Portugal

Michael Ash United States

Tristan Wegner Germany

Elena Garrido Spain

Gopal Vyas

63 ×0.6

PMH

57 ×0.8

17 ×0.4

17 ×0.6

PHILO

3 ×0.1

Citations per year, relative to Gopal Vyas Gopal Vyas (= 1×) peers Elena Garrido

Countries citing papers authored by Gopal Vyas

Since Specialization

Citations

This map shows the geographic impact of Gopal Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gopal Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gopal Vyas more than expected).

Fields of papers citing papers by Gopal Vyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gopal Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gopal Vyas. The network helps show where Gopal Vyas may publish in the future.

Co-authorship network of co-authors of Gopal Vyas

This figure shows the co-authorship network connecting the top 25 collaborators of Gopal Vyas. A scholar is included among the top collaborators of Gopal Vyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gopal Vyas. Gopal Vyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Vyas, Gopal, Daniel Roche, Heather A. Adams, et al.. (2025). Case Report: Metabolic, inflammatory, and neurological improvements after a ketogenic diet in a woman with treatment-resistant schizophrenia and metabolic syndrome. Frontiers in Psychiatry. 16. 1710785–1710785.

Buchanan, Robert W., Matthew Glassman, Heather A. Adams, et al.. (2024). Prebiotic Treatment in People With Schizophrenia. Journal of Clinical Psychopharmacology. 44(5). 457–461. 3 indexed citations

Glassman, Matthew, Bethany A. DiPaula, Heidi J. Wehring, et al.. (2022). Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness. Schizophrenia Research. 243. 163–169. 3 indexed citations

Kelly, Deanna L., et al.. (2021). Feasibility and Patient-Reported Satisfaction Using A Novel Point-Of-Care Fingerstick Method for Monitoring Absolute Neutrophil Count for Clozapine. Annals of Clinical Psychiatry. 33(2). 116–123. 1 indexed citations

Ponomareva, Olga, Heidi J. Wehring, Gopal Vyas, et al.. (2020). L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia. Schizophrenia Bulletin Open. 1(1). 1 indexed citations

Kelly, Deanna L., Matthew Glassman, Jae H. Park, et al.. (2020). O9.1. SATISFACTION WITH USING A NOVEL FINGERSTICK FOR ABSOLUTE NEUTROPHIL COUNT (ANC) AT THE POINT OF TREATMENT IN PATIENTS TREATED WITH CLOZAPINE. Schizophrenia Bulletin. 46(Supplement_1). S20–S21. 1 indexed citations

Kitchen, Christopher, Gopal Vyas, Nathan A. Siegfried, et al.. (2020). Comparison of Novel Immunoassay With Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) for Therapeutic Drug Monitoring of Clozapine. Therapeutic Drug Monitoring. 42(5). 771–777. 12 indexed citations

Wehring, Heidi J., Joseph P. McEvoy, Gopal Vyas, et al.. (2017). Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels. Psychiatric Quarterly. 89(1). 73–80. 16 indexed citations

Vyas, Gopal, Ann Hackman, Charles M. Richardson, et al.. (2017). Clozapine in Reducing Aggression and Violence in Forensic Populations. Psychiatric Quarterly. 89(1). 157–168. 26 indexed citations

10.

Wonodi, Ikwunga, et al.. (2017). 120. Benign Ethnic Neutropenia in a Sample of Nigerian Healthy Controls and Clozapine-Treated Schizophrenia Patients With DARC Null Variant. Schizophrenia Bulletin. 43(suppl_1). S67–S67. 2 indexed citations

11.

Richardson, Charles M., et al.. (2016). Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia. The Journal of Clinical Psychiatry. 77(11). e1454–e1459. 9 indexed citations

12.

Richardson, Charles M., et al.. (2015). The Risk of Suicide after Clozapine Discontinuation: Cause for Concern. Annals of Clinical Psychiatry. 27(4). 253–256. 22 indexed citations

13.

Kelly, Deanna L., Hadar Ben‐Yoav, Gregory F. Payne, et al.. (2015). Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device. Clinical Schizophrenia & Related Psychoses. 12(1). 23–30. 32 indexed citations

14.

Kelly, Deanna L., Heidi J. Wehring, & Gopal Vyas. (2012). Current status of clozapine in the United States.. PubMed. 24(2). 110–3. 12 indexed citations

15.

Wehring, Heidi J., Mary R. Lee, Robert P. McMahon, et al.. (2012). Poster #220 INTRANASAL OXYTOCIN EFFECTS ON SOCIAL ANXIETY AND DEPRESSION IN SCHIZOPHRENIA: RESULTS FROM A DOUBLE BLIND PLACEBO CONTROLLED TRIAL. Schizophrenia Research. 136. S360–S360. 2 indexed citations

16.

Lipsky, Robert H., et al.. (2001). DNA Melting Analysis for Detection of Single Nucleotide Polymorphisms. Clinical Chemistry. 47(4). 635–644. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact